Pharma channel feed – Endpoints News

Pharma channel feed

The compassionate use poll: A lopsided vote favors posting policies, with plenty of fretting

9 years ago

Say what? Compassionate use program? What compassionate use program?

9 years ago

The Sarepta dilemma: Bioethics expert Arthur Caplan says it’s time to rethink how to regulate compassion

9 years ago

Takeda adds a $790M discovery deal to an ongoing R&D overhaul

9 years ago

Pfizer plots a big move (but it's not going very far)

9 years ago

Teva hands Celltrion $160M to grab US rights on two biosimilars of Roche blockbusters

9 years ago

Feds help NewLink, Merck out with some added cash for Ebola vaccine

9 years ago

Hold the applause: Big Pharma has little to brag about regarding 2016 R&D productivity

9 years ago

Novartis unveils a new global R&D structure, creating centers in Cambridge, MA and Basel

9 years ago

Novartis is uprooting another research group in ongoing global reorganization

9 years ago

Amgen joins a marquee list of partners jumping on Nuevolution’s discovery platform

9 years ago

Merrimack CEO is out as the biotech restructures, chopping its workforce and overhauling R&D

9 years ago

AstraZeneca hands off another Amgen-partnered drug in a $1.5B deal with an acquisitive Allergan

9 years ago

ImmunoGen's new CEO retrenches, axing 65 staffers and looking to thin pipeline

9 years ago

Novo Nordisk takes out the ax and aims at R&D, chopping 1,000 jobs

9 years ago

Genentech snares a PhI RAF inhibitor from Hanmi in $910M deal

9 years ago

Hub appeal: AstraZeneca is marshaling 350-plus R&D troops in new South San Francisco campus

9 years ago

GSK finds a buyer willing to take its Paris R&D site off its hands — for a hefty fee

9 years ago

Bristol-Myers Squibb brings Opdivo to a joint immuno-oncology program with Nektar’s new T cell amplifier

9 years ago

FDA deals out pain, handing out its third punishing slap down for opioid Remoxy

9 years ago

3 for 3 in PhIII: GW Pharma racing to the FDA after bagging another late-stage epilepsy success

9 years ago

Regeneron, Sanofi win red-carpet treatment at the FDA for a blockbuster contender

9 years ago

AbbVie digs in for a long war as Amgen bags first OK for a Humira biosimilar

9 years ago

UniQure CEO Soland makes a quick exit as execs hammer out a new strategy

9 years ago

First page Previous page 338 339 340341342 343 Next page Last page